What alternative medications can be used for anxiety after discontinuing Lexapro (escitalopram) due to weight gain, considering a patient's exacerbation of anxiety with Buproprion (bupropion)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Alternative Medications for Anxiety After Discontinuing Lexapro Due to Weight Gain

For patients who discontinued escitalopram (Lexapro) due to weight gain and experienced anxiety exacerbation with bupropion, sertraline or fluoxetine are recommended as first-line alternatives due to their weight-neutral profiles and established efficacy for anxiety disorders.

Understanding the Problem

When selecting an alternative medication for anxiety after discontinuing escitalopram due to weight gain, several key factors must be considered:

  1. Weight impact profile of potential medications
  2. Efficacy for anxiety disorders
  3. Previous adverse reaction to bupropion
  4. Individual patient characteristics

Medication Options Based on Weight Profile

Weight-Neutral or Weight-Loss Promoting Options:

  • Fluoxetine (Prozac):

    • Associated with weight loss during short-term use and weight neutrality with long-term use 1
    • Effective for anxiety disorders
  • Sertraline (Zoloft):

    • Associated with weight loss during short-term use and weight neutrality with long-term use 1
    • Demonstrated efficacy for various anxiety disorders

Weight-Gain Associated Options (to avoid):

  • Paroxetine (Paxil): Highest weight gain potential among SSRIs 1
  • Mirtazapine (Remeron): Associated with significant weight gain 1
  • Tricyclic antidepressants: Particularly amitriptyline has high weight gain potential 1

Why Bupropion Failed

Bupropion is the only antidepressant consistently shown to promote weight loss 1, which would seem ideal for a patient concerned about weight gain. However, it's contraindicated for patients with anxiety disorders:

  • Bupropion is activating and can exacerbate anxiety 1
  • It's specifically noted to be inappropriate for patients with anxiety disorders 2
  • Psychiatrists rarely prescribe bupropion when comorbid anxiety is present 2

First-Line Recommendations

  1. Sertraline (Zoloft):

    • Weight-neutral with long-term use 1
    • Demonstrated efficacy in multiple anxiety disorders 3
    • Well-tolerated with favorable side effect profile
  2. Fluoxetine (Prozac):

    • Weight-neutral with long-term use 1
    • Effective for anxiety disorders
    • Less likely to cause sexual dysfunction than some other SSRIs

Second-Line Options

  1. Escitalopram at Lower Dose:

    • If the patient had good anxiety response to escitalopram
    • Lower doses may mitigate weight gain while maintaining efficacy
    • Consider adjunctive weight management strategies
  2. Venlafaxine (Effexor):

    • SNRI with efficacy for anxiety disorders
    • Generally weight-neutral for most patients

Medications to Avoid

  1. Bupropion (already failed):

    • Known to exacerbate anxiety 1
    • Not appropriate for patients with anxiety disorders 2
  2. Paroxetine:

    • Highest weight gain potential among SSRIs 1
  3. Mirtazapine:

    • Significant weight gain potential 1

Monitoring Recommendations

  • Follow up within 2-4 weeks after initiating new medication
  • Monitor weight at each visit
  • Assess anxiety symptoms using standardized scales
  • Evaluate for other side effects, particularly those that may affect adherence

Adjunctive Strategies

  • Consider cognitive behavioral therapy (CBT) for anxiety
  • Lifestyle modifications including regular physical activity and dietary changes
  • Sleep hygiene practices

Important Caveats

  • Weight changes vary considerably between individuals on the same medication
  • The transition period between medications may temporarily worsen anxiety symptoms
  • Start new medications at low doses and titrate gradually to minimize side effects
  • Some patients may require combination therapy if monotherapy is insufficient

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Why isn't bupropion the most frequently prescribed antidepressant?

The Journal of clinical psychiatry, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.